Tweet
<img alt="" height="1" width="1" />
Medivation cancer drug impresses; shares double
Reuters
(Reuters) - An experimental prostate cancer drug from Medivation Inc helped patients live longer in a late-stage study, sending the company's shares soaring on hopes that it will become a strong contender in an estimated ...
Medivation More Than Doubles on Cancer Drug Trial DataBusinessWeek
Medivation Scores Big Prostate Cancer Drug VictoryTheStreet.com
Medivation drug boosts prostate cancer survivalMarketWatch
Bloomberg -Xconomy -FierceBiotech
all 28 news articles »
More...